Xiang Yang Lu
Chief Executive Officer at LAEKNA, INC.
Net worth: 39 M $ as of 29/04/2024
Profile
Xiang Yang Lu is the founder of Laekna Therapeutics (Shanghai) Co., Ltd.
and Laekna, Inc. both founded in 2016.
He is currently a Director at Laekna Ltd.
Dr. Lu's former positions include Executive Director at Novartis Institutes for Biomedical Research, Inc. and China Novartis Institutes for BioMedical Research Co., Ltd.
He was also a Venture Partner at Frontline Bioventures.
Dr. Lu received his doctorate from The University of North Carolina at Chapel Hill in 1995, his graduate degree from Nankai University in 1988, and his undergraduate degree from Nankai University in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LAEKNA, INC.
12.72% | 29/06/2023 | 49,603,870 ( 12.72% ) | 39 M $ | 29/04/2024 |
Xiang Yang Lu active positions
| Companies | Position | Start |
|---|---|---|
| LAEKNA, INC. | Chief Executive Officer | 28/07/2016 |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Founder | 30/11/2016 |
| Laekna Ltd. | Director/Board Member | - |
Former positions of Xiang Yang Lu
| Companies | Position | End |
|---|---|---|
| China Novartis Institutes for BioMedical Research Co., Ltd. | Director/Board Member | 29/02/2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Director/Board Member | 29/02/2016 |
| Frontline Bioventures | Corporate Officer/Principal | - |
Training of Xiang Yang Lu
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| Nankai University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Frontline Bioventures | Finance |
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| China Novartis Institutes for BioMedical Research Co., Ltd. | |
| Laekna Ltd. |
- Stock Market
- Insiders
- Xiang Yang Lu
